Shares of Humana, which offers Medicare Advantage plans, dropped 6% in recent trading. Aetna parent CVS Health (CVS) saw its stock fall close to 3%, while UnitedHealth Group (UNH) slid about 2%.

Humana (HUM) and UnitedHealth (UNH) stocks are sliding amid a Medicare crackdown. Digital health company Hinge Health (HNGE) debuts on the NYSE, opening at $39.25 per share — higher than the ...

Investing.com -- Shares of major health insurers UnitedHealth (NYSE:UNH), Humana (NYSE:HUM), and CVS (NYSE:CVS) fell sharply today, with UnitedHealth down 4%, Humana declining 5%, and CVS dropping ...

Bengaluru: Health insurer Humana on Wednesday reported lower-than expected medical costs in the first quarter, allaying investor concerns about the sector after bellwether UnitedHealth's ...

Humana also beat quarterly profit estimates by a large margin, lifting shares of most other insurers, while broader markets were down. Shares of UnitedHealth were down 1.5%. Sign up here.

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance space. Both operate in the managed healthcare space, offering health ...

Managed care firms UnitedHealth (NYSE:UNH), Humana (NYSE:HUM), and CVS Health (NYSE:CVS) led the gainers in the S&P 500 on Tuesday after the U.S. Centers for Medicare & Medicaid Services finalized ...

Humana, UnitedHealth, and Aetna owner CVS were among those that saw share gains. The higher rate could help ease the funding pressure insurers face, UBS analysts said. Shares of health insurance ...

The Centers for Medicare and Medicaid Services set next year’s Medicare Advantage payment rates above expectations, in a move that’s putting health-insurance stocks on track for big gains in ...

But Humana Inc.'s stock (HUM) rose more than 11% in Monday's after-hours action, while CVS Health Corp.'s stock (CVS) gained 6.5% and UnitedHealth Group Inc.'s stock (UNH) advanced nearly 6%.

Bethesda, MD, March 20, 2025 (GLOBE NEWSWIRE) -- Aledade has announced the expansion of its collaboration with ... while the worst include UnitedHealth Group and Regeneron Pharmaceuticals.